Testing effectiveness (Phase 2)Study completedNCT03029247
What this trial is testing
Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
Who this might be right for
Anaemia
GlaxoSmithKline 105